Published in Pneumonol Pol on January 28, 1982
Plasma cortisol concentrations in patients with different circadian pain rhythm. Pain (1983) 0.79
The short metyrapone test in chronic headache patients. Funct Neurol (1987) 0.76
[Beta-endorphin levels in the blood and cerebrospinal fluid in humans]. Neurol Neurochir Pol (1986) 0.75
[Role of arachidonic acid (ETE) and its metabolites in the pathogenesis of bronchial spasm. II. Metabolites formed under the effect of lipoxygenase]. Pneumonol Pol (1983) 0.75
[Protracted steroid therapy in asthma. II. Immunoglobulins in endogenic asthma]. Pneumonol Pol (1980) 0.75
[Evaluation of various immunobiochemical indicators in the serum and bronchoalveolar washings of patients with bronchiectasis and atopic asthma]. Pneumonol Pol (1984) 0.75
[Clinical pharmacology of zidovudine]. Pol Tyg Lek (1988) 0.75
[Assessment of perfusion disorders in asthma by means of lung scintiscanning]. Pol Tyg Lek (1976) 0.75
[Controlled treatment with digoxin]. Wiad Lek (1977) 0.75
[Lanatoside C concentration in the blood serum of patients treated with this drug]. Pol Tyg Lek (1979) 0.75
[Determination of blood level of diphenylhydantoin in the treatment of epilepsy. The need for monitoring]. Wiad Lek (1977) 0.75
[Histamine changes in asthmatic conditions]. Pol Tyg Lek (1973) 0.75
[Comparative evaluation of diagnostic skin tests and blastic lymphocyte transformation in patients with asthma]. Pol Tyg Lek (1974) 0.75
[Contraction-dilation correlation in patients with reversible bronchial narrowing]. Gruzlica (1972) 0.75
[Role of adrenergic receptors in the mechanism of bronchial spasm]. Wiad Lek (1974) 0.75
[Retrospective studies on psychosocial circumstances preceding the occurrence of peptic ulcer (author's transl)]. Przegl Lek (1979) 0.75
[Treatment of jaw fractures with reference to own therapeutic methods]. Czas Stomatol (1975) 0.75
[Effect of Zaditen on the clinical status and ventilatory parameters in patients with various types of bronchial asthma]. Pneumonol Pol (1985) 0.75
[The treatment of mandibular fractures, complicated by inflammations in the fracture area, by means of xenogenic cartilage]. Stomatol DDR (1978) 0.75
[Changes in various immunobiochemical parameters in patients with bronchial asthma during specific desensitization]. Pneumonol Pol (1984) 0.75
[Injection of a depot glucocorticoid in asthmatic patients. Changes in the biochemical parameters and clinical symptoms]. MMW Munch Med Wochenschr (1982) 0.75
[Effect of aminophylline dosage on plasma drug level]. Pol Arch Med Wewn (1986) 0.75
[Diagnostic significance of alpha-2 macroglobulins in internal diseases. I. Asthma]. Pol Arch Med Wewn (1978) 0.75
[Comparative evaluation of the usefulness of various methods for studying the serum IgE levels in the diagnosis of atopic bronchial asthma]. Pol Tyg Lek (1987) 0.75
[Activity of acid hydrolases (acid phosphatase and beta-glucoronidase) and fructose level in the plasma of human semen]. Pol Tyg Lek (1966) 0.75
[An apparatus for repositioning of maxillary fractures with separation of palatal processes]. Czas Stomatol (1971) 0.75
The comparative evaluation of alpha-2-macroglobulin and immunoglobulin levels in sera of patients with bronchial asthma. Allerg Immunol (Leipz) (1983) 0.75
[Role of arachidonic acid (ETE) and its metabolites in the pathogenesis of bronchial spasm. I. Metabolites formed under the effect of cyclooxygenase]. Pneumonol Pol (1983) 0.75
Activity of acid hydrolases (acid phosphatase and beta-glucuronidase) and level of fructose in the plasma of human semen. Pol Med J (1967) 0.75
[Relationship between digoxin concentration in saliva and serum]. Pol Tyg Lek (1978) 0.75
[Comparison of the clinical effects to the kinetics of prostaglandin (PGF2 alpha), cAMP, cortisol and ACTH behavior in the plasma of bronchial asthma patients treated with triamcinolone acetonide]. Pol Arch Med Wewn (1982) 0.75
[Comparative study of blood serum concentrations of digoxin and lanatoside C after single oral administration]. Wiad Lek (1979) 0.75
Twenty-four-hour changes of plasmatic level of beta-endorphin-like substances in healthy humans. (Preliminary report). Acta Med Pol (1982) 0.75
[Principles of drug therapy monitored by determination of blood serum drug concentration]. Wiad Lek (1979) 0.75
[Internal carotid artery injury caused by cranio-facial trauma]. Otolaryngol Pol (1979) 0.75
[Mechanisms of action and clinical use of converting enzyme inhibitors]. Pol Tyg Lek (1986) 0.75
Twenty-four-hour changes of plasmatic beta-endorphine-like immunoreactivity in healthy humans. Acta Med Pol (1983) 0.75
[Exudative pleurisy in viral infection. Preliminary evaluation of diagnostic possibilities]. Pneumonol Pol (1986) 0.75
[Sisomicin dosage in renal failure]. Wiad Lek (1979) 0.75
[Clinical aspects of the fate of drugs in the body]. Pol Tyg Lek (1984) 0.75
[Angiotensin converting enzyme inhibitors--a new group of hypotensive drugs]. Wiad Lek (1984) 0.75
[Intal in the treatment of atopic extrinsic bronchial asthma. I. Effect on the ventilatory function]. Gruzlica (1974) 0.75
[Diagnosis of specific hypersensitivity to exogenous allergens by the raidallergosorbent test (RAST). I. Method and study of specificity of standard allergens in the Phadebas RAST kit]. Pol Arch Med Wewn (1979) 0.75
[Serum levels of specific and nonspecific IgE in blood donors]. Pol Tyg Lek (1988) 0.75
[Treatment of fractures of the edentulous mandible with particular reference to author's own method]. Czas Stomatol (1970) 0.75
[Biological control of pharmacokinetics in elderly persons]. Pol Tyg Lek (1985) 0.75
[Theophylline in the serum and bronchoalveolar lavage fluid (BALF) in patients with bronchospastic conditions]. Pneumonol Pol (1988) 0.75
[Usefulness of the dynamic spirometric indices in the assessment of the provocation test in some types of bronchial asthma]. Gruzlica (1975) 0.75
[Protracted steroid therapy in asthma. I. Immunoglobulins in atopic asthma]. Pneumonol Pol (1980) 0.75
[T lymphocyte subpopulations OKT-4 and OKT-8 in patients with bronchial asthma]. Pol Tyg Lek (1987) 0.75
[Sisomicin pharmacokinetics after a single intravenous dose]. Wiad Lek (1979) 0.75
[Fractures of jaw bones in children]. Czas Stomatol (1970) 0.75
[Usefulness of pulmonary scintigraphy in the diagnosis of pulmonary embolism]. Pneumonol Pol (1988) 0.75
[Metallic cap of own design for treatment of maxillofacial fractures]. Czas Stomatol (1971) 0.75
[Psychological aspects of the pathogenesis of pain]. Przegl Lek (1989) 0.75
[Effect of Zaditen on plasma immunoglobulin levels in patients with bronchial asthma]. Pneumonol Pol (1985) 0.75
[Clinical pharmacology of captopril]. Pol Tyg Lek (1983) 0.75
[Diagnostic value of radioimmunological studies (RIA) as tests differentiating and defining bronchial asthma]. Pneumonol Pol (1980) 0.75
[Diagnosis of specific hypersensitivity to exogenous allergens by the radioallergosorbent test (RAST). II. Inhalatory allergens as risk factors in the development of asthma]. Pol Arch Med Wewn (1979) 0.75
[Preliminary studies of using plasmapheresis in the treatment of status asthmaticus in atopic bronchial asthma]. Pol Tyg Lek (1987) 0.75
[Attempt at evaluation of various symptoms in peptic ulcer]. Folia Med Cracov (1978) 0.75
[Middle lobe syndrome]. Wiad Lek (1967) 0.75
[Lyophilized xenogenic cartilage in surgical treatment of mandibular fractures complicated with osteitis]. Czas Stomatol (1970) 0.75
[Concentration of PGE and 13,14-dihydro-15-keto-PGF2 alpha in bronchial asthma during corticotherapy]. Pneumonol Pol (1980) 0.75
[Studies on localization of the activity of certain lysozyme enzymes in human sperm]. Ginekol Pol (1968) 0.75
[Comparison of the effects of Kenalog and Zaditen on the clinical state and plasma cAMP levels of patients with bronchial asthma]. Pneumonol Pol (1985) 0.75
[Evaluation of selection of peptic ulcer patients for treatment in a santorium]. Wiad Lek (1968) 0.75
[Universal orthopedic first-aid apparatus for the treatment of edentulous maxilla and mandible]. Czas Stomatol (1970) 0.75
[Evaluation of the bioavailability of Polfa phenytoin tablets]. Neurol Neurochir Pol (1978) 0.75
[Reduction of fractured and displaced bones and jugular arch with a two-pronged hook of own design]. Czas Stomatol (1977) 0.75
The depot-form of glucocorticoid decreases cortisol but not ACTH and beta-endorphin levels in human plasma. Horm Metab Res (1983) 0.75
[Illustration of the influence of dental foci on inflammatory conditions of the eye]. Klin Oczna (1969) 0.75
[IgE level in patients with asthma]. Pol Arch Med Wewn (1976) 0.75
[Effect of Atrovent (ipratropium bromide) on the mechanics of respiration in patients with chronic obstructive pulmonary disease]. Pneumonol Pol (1986) 0.75
[Intal in the treatment of atopic extrinsic bronchial asthma. II. Effect of intal on histamine concentration and blastic index in peripheral blood]. Gruzlica (1974) 0.75
[Surgical-prosthetic management of various hypertrophic mucosal inflammatory processes of the edentulous maxilla and mandible]. Protet Stomatol (1984) 0.75
[Surgical-prosthetic therapy of jaw defects after cyst removal]. Protet Stomatol (1980) 0.75
[Usefulness of immunological in vitro tests in the diagnosis of asthma with particular reference to radioimmunoassay]. Pol Tyg Lek (1977) 0.75
[Long-term therapy using beclomethasone preparations in our experience]. Pneumonol Pol (1988) 0.75
[Repositioning of the fractured and displaced bones of the zygomatic arch with a 2-pronged hook of our personal design]. Czas Stomatol (1985) 0.75
[Clinical evaluation of triamcinolone and paramethasone in the treatment of chronic asthma]. Pneumonol Pol (1976) 0.75
[Primary carcinoma of the oviduct]. Wiad Lek (1967) 0.75
[Effect of inflammatory processes on the healing of jaw fractures]. Czas Stomatol (1975) 0.75
[Treatment of jaw fractures with narrowing of the dental arch using a mettalic apparatus]. Czas Stomatol (1972) 0.75
[Basic immunoglobulin level in asthma treated with delayed-action corticosteroids]. Pneumonol Pol (1980) 0.75
[Clinical significance of F2-alpha hyperprostaglandinemia in the diagnosis of bronchial asthma]. Pneumonol Pol (1982) 0.75
[Kinetics of plasma cyclic AMP level in atopic and non-atopic bronchial asthma after administration of triamcinolone acetonide]. Pneumonol Pol (1982) 0.75
[Proteolytic enzymes and their natural inhibitors in patients with bronchiectasis]. Wiad Lek (1987) 0.75
[Effect of aminophylline on plasma digoxin level in patients during long-term digitalization]. Wiad Lek (1986) 0.75
[Pharmacology and clinical pharmacokinetics of nadolol]. Pol Tyg Lek (1981) 0.75
[Antiviral drugs]. Pol Tyg Lek (1988) 0.75
[Evaluation of the behavior of intravascular granulocyte pools in bronchial asthma patients treated with Kenalog]. Pneumonol Pol (1981) 0.75
[Effect of water inhalation from bore No. 15 at Busko-Zdrôj on the iodine metabolism of the organism]. Przegl Lek (1969) 0.75
[Lymphocyte transformation test and blood histamine level in bronchial asthma in exacerbations and remissions]. Wiad Lek (1973) 0.75